HealthCare Global

HCG reported a consolidated net profit of Rs 20.68 crore in the second quarter of financial year 2025, as against Rs 10.78 crore in the same quarter of the previous year

This came after HCG said that it has acquired 51 per cent stake in Vizag Hospital with remaining 49 per cent equity to be acquired later in two tranches

HCG's network presently encompasses 21 comprehensive cancer centres with 24 hospitals across India and Africa, and seven daycare centres

The private equity firm is looking to identify buyers for its 60.4% in the Mumbai-listed company, said the people, who asked not to be identified as the information is private

Experts note that the transition of the sector to the asset-light model has significantly enabled it to use fewer funds for setting up hospitals, thus bringing significantly higher returns on equity

Germany's Siemens Healthineers on Friday announced strategic partnerships with HealthCare Global Enterprises, Narayana Health and the Indian Institute of Science as part of its strategy to make India an innovation centre for its global operations. The medical technology company said the partnerships will focus on fighting the most threatening diseases, enabling efficient operations and expanding access to patient care. In a virtual press conference, Siemens Healthineers Chief Technology Officer Peter Schardt said the partnership with HealthCare Global Enterprises Ltd (HCG) will focus on advancing cancer care with patient-centric solutions for the entire clinical pathway. It will also look to enhance research on diagnostic imaging technologies, artificial intelligence and precision therapy based on intelligent and image-guided treatment. With Narayana Health (NH), Schardt said the focus will be on improving cardiovascular care and the usage of interdisciplinary solutions to optimise

HealthCare Global Enterprises Limited said it has become a majority stakeholder in Suchirayu Healthcare Solutions with the acquisition of additional 60.9 per cent for an undisclosed sum

The weekly increase surpassed the previous high set in mid-December

It operates one of the largest cancer-care networks in the country, with 14 comprehensive cancer centres.

Scarcity premium and higher valuations may not sustain; best-case scenario factored in

The Rs 650 crore issue received bids for 25.3 mn shares against the total issue size of 16.39 mn shares.

Most of the bids came from institutional investors

Ability to quickly scale up network and improve profitability will be key

The company has set the price band for the IPO between Rs 205 and Rs 218 per share